Polyamide analogs of DNA, or peptide nucleic acid (PNA), were first proposed in 1991 by a group of chemists and biochemists in a memorable Science paper [1] . At that time, it was astonishing that such a dramatic change in the structure of nucleic acids, i.e., subsituting the sugar-phosphate backbone with a polyamide constituted of repeated N-(2-aminoethyl)glycine units, could give rise to molecules that not only behaved like DNA, but also showed improved binding propeties and improved selectivity. Since then, PNA has attracted the interest of a growing number of scientists in several fields [2] . This Special Issue provides a good overview of these various fields and of the vitality of the research into these molecules.
(anti-miR) levels. In particular, these approaches can be useful for some diseases that do not currently have efficient pharmacological treatments, as illustrated by the two papers dealing with the regulation of cystic fibrosis processes. Giorgia Oliviero and coworkers report using PNAs in a 'masking' approach to limit microRNA activity [13] , while Roberto Gambari and collaborators show the possibility of increasing cystic fibrosis conductance regulator (CFTR) levels by acting with anti-miR PNAs [14] . Thus, new perspectives are arising for the treatment of this severe and debilitating disease.
The appropriate tailoring of the PNA structure has provided new solutions and new applications in molecular biology, based on the reactions induced by the PNA on its target. The review by Makoto Komiyama and collaborators describes the use of PNA as an inducer of DNA cutting for gene repair and gene editing, which allows the manipulation of DNA and overcomes the limitations of the sequences presented by restriciton enzymes [8] . The paper by Roger Stromberg and co-workers illustrates the possibility of inducing hydrolytic cleavage in target RNA, thus creating precise, artificial, RNAse-like activity [7] .
Gene editing techniques have become a field of major interest in biology and medicine, and an increasing number of applications for these can be envisaged in the near future. In addition to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), Transcription activator-like effector nucleases (TALEN), and zinc finger nuclease techniques, PNA-based approaches have also been described. The very interesting and up-to-date review by Peter Glazer and co-workers describes very well how these molecules can outperform the present standard methods in terms of precision, showing reduced off-target effects [15] . This field is certainly one of the most promising for the future of PNA applications.
Finally, although still rarely considered, PNA can be a component of the so-called 'DNA nanotechnology', and is especially suitable due to its chemical robustness and properties of self-assembly and hetero-association with natural nucleic acids. Nanoassembly, molecular machines, switches and logic gates can be designed using PNAs as components or as switching stimuli. A good example of this is reported by Kenji Usui and co-workers in this issue, where a DNA G-quadruplex secondary structure and nanostructural shape were shown to be affected by PNA switching segments [16] .
Thus, we can conclude that the present issue of Molecules shows how PNA technology is still improving and that new applications and new knowledge is still arising from the study of this class of molecules, which has been researched for 27 years but has still not been fully explored.
